<<First
<Prev
Next>
Last>>
Search Results for:
|
Catalogue No |
Partner |
Description |
Species |
Application |
|
130-10844-100
|
RayBiotech, Inc.
|
Mouse anti-SARS-CoV-2 S1RBD (4A9-C2-G3-F10), Mouse Monoclonal Antibody
|
Virus
|
ELISA (recommended work dilution = 1:320,000)<br><br>Neutralization was measured by ability to inhibit entry of pseudovirus harboring the SARS-CoV-2 spike protein into A549 cells. This antibody was also demonstrated to block S1 RBD-ACE2 binding <em>in vitro</em>.
|
|
130-10844B-50
|
RayBiotech, Inc.
|
Mouse anti-SARS-CoV-2 S1RBD (4A9-C2-G3-F10) [+Biotin], Mouse Monoclonal Antibody
|
Virus
|
ELISA (recommended work dilution = 1:320,000)<br><br>Neutralization was measured by ability to inhibit entry of pseudovirus harboring the SARS-CoV-2 spike protein into A549 cells. This antibody was also demonstrated to block S1 RBD-ACE2 binding <em>in vitro</em>.
|
|
130-10845-100
|
RayBiotech, Inc.
|
Mouse anti-SARS-CoV-2 S1RBD (1F9-F2-C1-G9), Mouse Monoclonal Antibody
|
Virus
|
ELISA (recommended work dilution = 1:320,000)<br><br>Neutralization was measured by ability to inhibit entry of pseudovirus harboring the SARS-CoV-2 spike protein into A549 cells. This antibody was also demonstrated to block S1 RBD-ACE2 binding <em>in vitro</em>.
|
|
130-10845B-50
|
RayBiotech, Inc.
|
Mouse anti-SARS-CoV-2 S1RBD (1F9-F2-C1-G9) [+Biotin], Mouse Monoclonal Antibody
|
Virus
|
ELISA (recommended work dilution = 1:320,000)<br><br>Neutralization was measured by ability to inhibit entry of pseudovirus harboring the SARS-CoV-2 spike protein into A549 cells. This antibody was also demonstrated to block S1 RBD-ACE2 binding <em>in vitro</em>.
|
|